It means that even if the patient has stopped taking the medication, did not complete the assigned tx, or has been switched to an active alternative therapy, the data from the patient is included in the original tx group to which pt. is randomized. Lessen the likelihood of finding a difference between the treatments It is more analogous to what happens outside the clinical trial situation. It is the statistical feature of clinical trials